NIH-funded research Fellowship grant

Investigating how HIV treatment affects brain cell development

Official title: Stress Granule Formation in the Antiretroviral-Mediated Dysregulation of Oligodendrocyte Maturation in HIV-HAND

Funded at University of Pennsylvania · NIH-10914660 · Data updated 2026-11-12

This study is looking at how HIV treatment affects brain cells that help keep your mind healthy, and it aims to find ways to improve brain health for people living with HIV who are on this treatment.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 1, 2023
Project endJune 30, 2026
Funding year2024
Award (this year)$48,974
NIH project number5F31MH134723-02
Project IDNIH-10914660 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who are experiencing neurocognitive impairments or are at risk for HIV-Associated Neurocognitive Disorder (HAND).

Less likely to help

Patients who are not living with HIV or those who do not exhibit any cognitive impairments related to HIV may not benefit from this research.

What this research studies

This research focuses on understanding how antiretroviral therapy (ART) impacts the maturation of oligodendrocytes, which are crucial for maintaining healthy brain function in individuals living with HIV. It examines the relationship between ART and the formation of stress granules in these cells, which may hinder their development and contribute to neurocognitive disorders. By exploring the mechanisms behind these effects, the study aims to identify potential interventions that could improve brain health in patients undergoing ART.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies that enhance brain health and cognitive function in individuals living with HIV.

How similar studies have gone: Previous research has shown that ART can negatively impact oligodendrocyte maturation, indicating that this area of investigation is both relevant and necessary for understanding HAND.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Von Krusenstiern, Eliana Vera — University of Pennsylvania
  • Study coordinator: Von Krusenstiern, Eliana Vera

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.